Moving Generalized Myasthenia Gravis Care Beyond Long-Term High-Dose Prednisone

Author profile image Aggregator
0 comments
Karissa L. Gable, MD, and a pannel of clinicians discussed how targeted therapies are changing steroid use, bridging and treatment sequencing in generalized myasthenia gravis at an October 15, 2026, forum in Morrisville, North Carolina.

Source: NeurologyLive Published 21 Nov 2026 Imported 21 Nov 2026 Relevancy: Not reviewed

Read the article